Monoclonal antibody LYM-1-I-131

N/A

Report date: 2025/10/20 14:43:53

Base Information

Drug NameMonoclonal antibody LYM-1-I-131
Drug Alias NameLym-1LYM-1-I-131Iodine 131-ILym-1Oncolym
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugateRadiation-emitting products > Nuclides > Iodine > 131I +[5] 
Mechanisms of ActionIonising radiation emittersAnti-CD74
TargetsHLA-DR antigens-associated invariant chain
Therapy Area/IndicationsLymphoma, Non-HodgkinLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwest University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthwest UniversityPeregrineSchering Pharma +[4] 
Active IndicationsN/A
Inactive IndicationsLymphoma, Non-HodgkinLymphoma

Other Information

ATC CodeN/A
Related LinksN/A